[Prevention of cerebrovascular insults]
- PMID: 7973532
[Prevention of cerebrovascular insults]
Abstract
Cerebrovascular infarction is the third leading cause of mortality following coronary heart disease and malignancies. WHO studies show that more than half of patients admitted for cerebrovascular infarction were not treated for hypertension. The risk factors for coronary heart disease and cerebrovascular infarction are not identical. Patients with systolic and diastolic hypertension, atrial fibrillation, stenosis of the carotid artery, and smoking, have a significantly elevated risk for cerebrovascular accidents. Hypercholesterolemia and diabetes are less important risk factors. Risk factors amendable by adequate nutritional intake are low supply of carotene and vitamin C. Homocysteineemia appears to be a risk factor that may be influenced by appropriate nutrition. Antihypertensive therapy is the most important primary and secondary preventive measure. No smoking and adequate dietary intake are also important. Primary prevention with low dose salicylic acid (ASA) is recommended in the presence of additional cardiovascular risk factors. The benefit of low dose anticoagulant therapy in atrial fibrillation without symptoms is not fully established. In subjects with atrial fibrillation with cerebrovascular events anticoagulants are superior to ASA. Surgical treatment of significant stenosis of the carotid artery is indicated. In secondary prevention of thromboembolic events, low dose ASA is recommended. A valuable alternative in case of side effects is available in ticlopidine.
Similar articles
-
[Antithrombotic therapy of atrial fibrillation].Arch Mal Coeur Vaiss. 1996 Nov;89(11 Suppl):1533-42. Arch Mal Coeur Vaiss. 1996. PMID: 9092415 Review. French.
-
[Epidemiology of cerebral infarction].Ann Radiol (Paris). 1994;37(1-2):7-10. Ann Radiol (Paris). 1994. PMID: 8179287 Review. French.
-
[Study of combined anticoagulant (fluindione)-aspirin therapy in patients with atrial fibrillation at high risk for thromboembolic complications. A randomized trial (FFAACS)].Therapie. 2000 Nov-Dec;55(6):681-9. Therapie. 2000. PMID: 11234463 Clinical Trial. French.
-
Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice.CMAJ. 1999 Sep 7;161(5):493-7. CMAJ. 1999. PMID: 10497604 Free PMC article. Clinical Trial.
-
[Cardiovascular risk factors and prevention in women: similarities and differences].Ital Heart J Suppl. 2001 Feb;2(2):125-41. Ital Heart J Suppl. 2001. PMID: 11255880 Review. Italian.